Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.
暂无分享,去创建一个
[1] Myeong Soo Lee,et al. Acupuncture for Hot Flushes in Perimenopausal and Postmenopausal Women: A Randomised, Sham-Controlled Trial , 2011, Acupuncture in medicine : journal of the British Medical Acupuncture Society.
[2] M. Harigopal,et al. Use of high‐risk human papillomavirus testing in patients with low‐grade squamous intraepithelial lesions , 2011, Cancer cytopathology.
[3] L. Boni,et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. , 2011, JAMA.
[4] E. Anckaert,et al. Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence. , 2011, Fertility and sterility.
[5] E. Warnecke. What works? Evidence for lifestyle and nonprescription therapies in menopause. , 2011, Australian family physician.
[6] J. Fish. Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk? , 2011, Journal of pediatric and adolescent gynecology.
[7] Stephanie J. Lee,et al. How I treat late effects in adults after allogeneic stem cell transplantation. , 2011, Blood.
[8] K. P. Jones,et al. Gynecologic Care in Hematopoietic Stem Cell Transplant Patients: A Review , 2010, Obstetrical & gynecological survey.
[9] A. Vishnu,et al. Mind-body therapies for menopausal symptoms: a systematic review. , 2010, Maturitas.
[10] A. Juul,et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. , 2010, Fertility and sterility.
[11] J. Jeruss,et al. Preservation of fertility in patients with cancer. , 2009, The New England journal of medicine.
[12] C. Wheeler,et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. , 2009, The Journal of infectious diseases.
[13] H. Deeg,et al. Solid cancers after allogeneic hematopoietic cell transplantation. , 2009, Blood.
[14] M. Asaka,et al. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] M. Hickey,et al. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] A. Barrett,et al. Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[17] L. Baden,et al. Vaccination after stem cell transplant: a review of recent developments and implications for current practice , 2008, Current opinion in infectious diseases.
[18] P. Stratton,et al. Labial Fusion: A Rare Complication of Chronic Graft-Versus-Host Disease , 2008, Obstetrics and gynecology.
[19] G. Dini,et al. Endocrinological late complications after hematopoietic SCT in children , 2008, Bone Marrow Transplantation.
[20] L. Schover. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] B. Kurland,et al. Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. , 2008, Blood.
[22] J. Voltarelli,et al. Ovarian recovery after stem cell transplantation , 2008, Bone Marrow Transplantation.
[23] A. Nademanee,et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. , 2007, Blood.
[24] M. Turner,et al. Vulvovaginal Chronic Graft-Versus-Host Disease With Allogeneic Hematopoietic Stem Cell Transplantation , 2007, Obstetrics and gynecology.
[25] S. Rose,et al. Long-term endocrine sequelae of childhood cancer , 2007, Current opinion in pediatrics.
[26] Ho-Joon Lee,et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] F. X. Bosch,et al. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions , 2007 .
[28] Daron G Ferris,et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. , 2007, The New England journal of medicine.
[29] C. Nappi,et al. Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review , 2007, Menopause.
[30] W. Au,et al. Challenges and pitfalls in prenatal screening in pregnancies involving allogeneic stem cell transplantation recipients , 2007, Bone Marrow Transplantation.
[31] J. Szer,et al. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management , 2006, Bone Marrow Transplantation.
[32] D. Green,et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. , 2006, Journal of the National Cancer Institute.
[33] L. Robison,et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the bone marrow transplant survivor study , 2006, Bone Marrow Transplantation.
[34] V. Pinn,et al. Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. , 2006, The Journal of reproductive medicine.
[35] A. Schattenberg,et al. Quality of life, reproduction and sexuality after stem cell transplantation with partially T-cell-depleted grafts and after conditioning with a regimen including total body irradiation , 2006, Bone Marrow Transplantation.
[36] L. Gerber,et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[37] F. Wojnarowska,et al. Influence of treatment of erosive lichen planus of the vulva on its prognosis. , 2006, Archives of dermatology.
[38] G. Christman,et al. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. , 2005, Arthritis and rheumatism.
[39] D. Panidis,et al. Function of the hypothalamic–pituitary–gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases , 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[40] F. Orio,et al. Endocrine disorders during the first year after autologous stem-cell transplant. , 2005, The American journal of medicine.
[41] W. Travis,et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. , 2005, Blood.
[42] Charles Sklar,et al. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. , 2005, Journal of the National Cancer Institute. Monographs.
[43] H. Critchley,et al. Impact of cancer treatment on uterine function. , 2005, Journal of the National Cancer Institute. Monographs.
[44] R. Soiffer,et al. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[45] J. Berzofsky,et al. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. , 2003, The Journal of infectious diseases.
[46] F. X. Bosch,et al. Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. , 2003, Journal of the National Cancer Institute. Monographs.
[47] J. Rock,et al. Treatment of vaginal agglutination associated with chronic graft-versus-host disease. , 2002, Fertility and sterility.
[48] R. Kaufman,et al. Treatment of Vulvovaginal Lichen Planus With Vaginal Hydrocortisone Suppositories , 2002, Obstetrics and gynecology.
[49] R. Storb,et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. , 2002, Blood.
[50] A. Bacigalupo,et al. Hormone Replacement Therapy and Chronic Graft‐versus‐Host Disease Activity in Women Treated with Bone Marrow Transplantation for Hematologic Malignancies , 2002, Annals of the New York Academy of Sciences.
[51] E. Norwitz,et al. Placenta Percreta and Uterine Rupture Associated With Prior Whole Body Radiation Therapy , 2001, Obstetrics and gynecology.
[52] A. Uutela,et al. Gender-associated differences in the quality of life after allogeneic BMT , 2001, Bone Marrow Transplantation.
[53] P. Ljungman,et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey , 2001, The Lancet.
[54] A. Nademanee,et al. Solid cancers after bone marrow transplantation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] F. Frassoni,et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation , 2000, British journal of haematology.
[56] I. Frazer,et al. HPV6b virus like particles are potent immunogens without adjuvant in man. , 2000, Vaccine.
[57] A. Tichelli,et al. Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation , 1999, Annals of Internal Medicine.
[58] R. Gray,et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone , 1999, Cancer.
[59] P. Ljungman,et al. Norethisterone Treatment, a Major Risk-Factor for Veno-Occlusive Disease in the Liver After Allogeneic Bone Marrow Transplantation , 1998 .
[60] C. Teinturier,et al. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure , 1998, Bone Marrow Transplantation.
[61] A. Schimmer,et al. Ovarian function after autologous bone marrow transplantation. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] G. Jackson,et al. Early high dose chemotherapy intensification with autologous bone marrow transplantation in lymphoma associated with retention of fertility and normal pregnancies in females. Scotland and Newcastle Lymphoma Group, UK. , 1997, Leukemia & lymphoma.
[63] R. Hoover,et al. Solid cancers after bone marrow transplantation. , 1997, The New England journal of medicine.
[64] C. Sklar,et al. Gonadal function after bone marrow transplantation for acute leukemia during childhood. , 1997, The Journal of pediatrics.
[65] P. Ljungman,et al. Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients. , 1996, Bone Marrow Transplantation.
[66] J. Lurain,et al. Unanticipated pregnancy with intrauterine growth retardation after radiation-induced ovarian failure. A case report. , 1996, Journal of reproductive medicine.
[67] A. Bacigalupo,et al. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. , 1994, Bone marrow transplantation.
[68] A. Goldstone,et al. Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients. , 1994, Bone marrow transplantation.
[69] D. Linch,et al. Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. , 1994, Bone marrow transplantation.
[70] J. Zucker,et al. Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood. , 1992, The Journal of pediatrics.
[71] R. Epstein,et al. Drug-induced DNA damage and tumor chemosensitivity. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] M. Whitehead,et al. Consequences and treatment of ovarian failure after total body irradiation for leukaemia. , 1989 .
[73] K. Sullivan,et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] K. Sullivan,et al. Gynecologic Manifestations of Chronic Graft-Versus-Host Disease , 1982, Obstetrics and gynecology.
[75] F. Martin,et al. Cyclophosphamide-induced ovarian failure. , 1973, The New England journal of medicine.
[76] M. Marechal,et al. Severe vaginal chronic graft-versus-host disease (GVHD): two cases with late onset and literature review. , 2010, European journal of gynaecological oncology.
[77] S. Pavletic,et al. Chronic Graft versus Host Disease: Interdisciplinary Management: Contents , 2009 .
[78] V. Stearns. Serotonergic Agents as an Alternative to Hormonal Therapy for the Treatment of Menopausal Vasomotor Symptoms , 2006, Treatments in endocrinology.
[79] A. Bacigalupo,et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. , 2003, Haematologica.